Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
6.80
+0.81 (13.52%)
At close: Jun 6, 2025, 4:00 PM
6.80
0.00 (0.00%)
Pre-market: Jun 9, 2025, 6:13 AM EDT
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $774.75 million as of June 9, 2025. Its market cap has increased by 2.31% in one year.
Market Cap
774.75M
Enterprise Value
546.18M
1-Year Change
2.31%
Ranking
Category
Stock Price
$6.80
Market Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $774.75M, an increase of 523.44%. That is a compound annual growth rate of 45.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 774.75M | -10.08% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | 350.40M | 181.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 691.15B |
| Johnson & Johnson | 373.01B |
| AbbVie | 335.32B |
| Novo Nordisk | 332.47B |
| UnitedHealth Group | 275.06B |
| Abbott Laboratories | 232.41B |
| Novartis AG | 231.17B |
| AstraZeneca | 226.14B |